Related Experiment Video
Updated: Sep 1, 2025

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
Published on: April 20, 2018
The Body Mass Index Paradox in Head and Neck Cancer: A Systematic Review and Meta-Analysis
Sara Hobday1, Maria Armache2, Rebecca Paquin3
1Department of Otorhinolaryngology-Head and Neck Surgery, University of Pennsylvania, Philadelphia, PA, USA.
The body mass index (BMI) paradox suggests higher BMI may improve survival in some cancers. For head and neck squamous cell carcinoma (HNSCC), being overweight (BMI 25-30) improves overall survival (OS), while underweight status worsens it.
Area of Science:
- Oncology
- Epidemiology
- Biostatistics
Background:
- The body mass index (BMI) paradox is observed in various cancers, where elevated BMI correlates with better patient survival.
- Head and neck squamous cell carcinoma (HNSCC) survival outcomes may be influenced by patient body mass index (BMI).
Approach:
- A systematic literature search identified studies reporting hazard ratios for BMI's impact on overall survival (OS) in HNSCC patients.
- Meta-analysis using random-effects DerSimonian and Laird methods synthesized data from included studies.
Key Points:
- Overweight patients (BMI 25–30 kg/m²) exhibited significantly lower hazards of death compared to normal weight individuals (BMI 18.5–25 kg/m²).
- This survival benefit associated with overweight status diminished for BMIs exceeding 30 kg/m².
- Underweight patients (BMI < 18.5 kg/m²) faced increased hazards of death relative to normal weight HNSCC patients.
Conclusions:
- Pretreatment overweight status (BMI up to 30 kg/m²) is a positive predictor of overall survival in HNSCC patients.
- Underweight status presents a prognostic disadvantage for HNSCC patients.
- Further research is required to elucidate the biological mechanisms underlying the association between body mass and survival in HNSCC.
More Related Videos
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
Related Concept Videos
Cancer Survival Analysis
Bias in Epidemiological Studies
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...